Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

Código QR

Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

Guardado en:

Detalles Bibliográficos
Autores principales:	Jinsung Yang, Simon J. L. Petitjean, Melanie Koehler, Qingrong Zhang, Andra C. Dumitru, Wenzhang Chen, Sylvie Derclaye, Stéphane P. Vincent, Patrice Soumillion, David Alsteens
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/1ba3ed91a8174383a81a4edd4703b94e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Jinsung Yang, et al.
Publicado: (2020)

Glycan-mediated enhancement of reovirus receptor binding
por: Melanie Koehler, et al.
Publicado: (2019)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Christopher J. Day, et al.
Publicado: (2021)

Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
por: Melanie Koehler, et al.
Publicado: (2021)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zengyuan Zhang, et al.
Publicado: (2021)

Neutral evolution test of the spike protein of SARS-CoV-2 and its implications in the binding to ACE2
por: Georgina I. López-Cortés, et al.
Publicado: (2021)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Yanqiu Gong, et al.
Publicado: (2021)

Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction.
por: Amit Mahindra, et al.
Publicado: (2021)

Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction
por: Amit Mahindra, et al.
Publicado: (2021)

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
por: James R. Byrnes, et al.
Publicado: (2020)

Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry
por: Anna Goc, et al.
Publicado: (2021)

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
por: Fang Tian, et al.
Publicado: (2021)

Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection
por: Philippe Karoyan, et al.
Publicado: (2021)

Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
por: Kushal Suryamohan, et al.
Publicado: (2021)

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
por: Jiwan Ge, et al.
Publicado: (2021)

In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Sakshi Piplani, et al.
Publicado: (2021)

Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor
por: Thassanai Sitthiyotha, et al.
Publicado: (2021)

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
por: Seiya Ozono, et al.
Publicado: (2021)

Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans
por: Xia Xue, et al.
Publicado: (2021)

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
por: Yannick Galipeau, et al.
Publicado: (2021)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
por: Michael I Barton, et al.
Publicado: (2021)

Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.
por: Van A Ngo, et al.
Publicado: (2021)

Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2
por: Jorge H. Rodriguez
Publicado: (2021)

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
por: Yusuke Higuchi, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Changhai Lei, et al.
Publicado: (2020)

Submolecular probing of the complement C5a receptor–ligand binding reveals a cooperative two-site binding mechanism
por: Andra C. Dumitru, et al.
Publicado: (2020)

Author Correction: Submolecular probing of the complement C5a receptor–ligand binding reveals a cooperative two-site binding mechanism
por: Andra C. Dumitru, et al.
Publicado: (2021)

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
por: Federico Bertoglio, et al.
Publicado: (2021)

Author Correction: In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin
por: Sakshi Piplani, et al.
Publicado: (2021)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Lily E. Adams, et al.
Publicado: (2021)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
por: Sieńko J, et al.
Publicado: (2020)

Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.
por: Van A Ngo, et al.
Publicado: (2021)

Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with ACE2 receptors
por: Marta Targosz-Korecka, et al.
Publicado: (2021)

Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction
por: Van A. Ngo, et al.
Publicado: (2021)

Author Correction: Reovirus directly engages integrin to recruit clathrin for entry into host cells
por: Melanie Koehler, et al.
Publicado: (2021)

Reovirus directly engages integrin to recruit clathrin for entry into host cells
por: Melanie Koehler, et al.
Publicado: (2021)

Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells
por: Hung Caohuy, et al.
Publicado: (2021)

Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor
por: Wantanee Treewattanawong, et al.
Publicado: (2021)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Shiho Tanaka, et al.
Publicado: (2021)

Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective
por: Yulong Wei, et al.
Publicado: (2021)